113 related articles for article (PubMed ID: 8893722)
1. Expression of vascular endothelial growth factor in pediatric and adult cerebral arteriovenous malformations: an immunocytochemical study.
Sonstein WJ; Kader A; Michelsen WJ; Llena JF; Hirano A; Casper D
J Neurosurg; 1996 Nov; 85(5):838-45. PubMed ID: 8893722
[TBL] [Abstract][Full Text] [Related]
2. Tie endothelial cell-specific receptor tyrosine kinase is upregulated in the vasculature of arteriovenous malformations.
Hatva E; Jääskeläinen J; Hirvonen H; Alitalo K; Haltia M
J Neuropathol Exp Neurol; 1996 Nov; 55(11):1124-33. PubMed ID: 8939195
[TBL] [Abstract][Full Text] [Related]
3. Early regrowth of juvenile cerebral arteriovenous malformations: report of 3 cases and immunohistochemical analysis.
Takagi Y; Kikuta K; Nozaki K; Hashimoto N
World Neurosurg; 2010 Feb; 73(2):100-7. PubMed ID: 20860935
[TBL] [Abstract][Full Text] [Related]
4. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
Bai J; Wang YJ; Liu L; Zhao YL
J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927
[TBL] [Abstract][Full Text] [Related]
5. Abnormal pattern of Tie-2 and vascular endothelial growth factor receptor expression in human cerebral arteriovenous malformations.
Hashimoto T; Emala CW; Joshi S; Mesa-Tejada R; Quick CM; Feng L; Libow A; Marchuk DA; Young WL
Neurosurgery; 2000 Oct; 47(4):910-8; discussion 918-9. PubMed ID: 11014431
[TBL] [Abstract][Full Text] [Related]
6. Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations.
Sure U; Butz N; Schlegel J; Siegel AM; Wakat JP; Mennel HD; Bien S; Bertalanffy H
J Neurosurg; 2001 Jun; 94(6):972-7. PubMed ID: 11409527
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of vascular endothelial growth factor after treatment for cerebral arteriovenous malformations.
Kim GH; Hahn DK; Kellner CP; Hickman ZL; Komotar RJ; Starke RM; Mack WJ; Mocco J; Solomon RA; Connolly ES
Stroke; 2008 Aug; 39(8):2274-9. PubMed ID: 18535271
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
[TBL] [Abstract][Full Text] [Related]
9. Expression of structural proteins and angiogenic factors in cerebrovascular anomalies.
Kiliç T; Pamir MN; Küllü S; Eren F; Ozek MM; Black PM
Neurosurgery; 2000 May; 46(5):1179-91; discussion 1191-2. PubMed ID: 10807251
[TBL] [Abstract][Full Text] [Related]
10. Expression of angiogenic factors and structural proteins in central nervous system vascular malformations.
Rothbart D; Awad IA; Lee J; Kim J; Harbaugh R; Criscuolo GR
Neurosurgery; 1996 May; 38(5):915-24; discussion 924-5. PubMed ID: 8727816
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of angiogenesis induced by cerebral arteriovenous malformations using gamma knife irradiation.
Kiliç K; Konya D; Kurtkaya O; Sav A; Pamir MN; Kiliç T
J Neurosurg; 2007 Mar; 106(3):463-9. PubMed ID: 17367070
[TBL] [Abstract][Full Text] [Related]
12. Expression and activation of STAT family proteins in cerebral arteriovenous malformations.
Aziz MM; Takagi Y; Hashimoto N; Miyamoto S
World Neurosurg; 2012 Nov; 78(5):487-97. PubMed ID: 22381273
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical study of vascular endothelial growth factor, relative receptors and ligands in vascular endothelial cells of cerebral arteriovenous malformation].
Li J; Gao Y; Zhao M
Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):675-8. PubMed ID: 11769600
[TBL] [Abstract][Full Text] [Related]
14. Recurrent cerebral arteriovenous malformations after negative postoperative angiograms.
Kader A; Goodrich JT; Sonstein WJ; Stein BM; Carmel PW; Michelsen WJ
J Neurosurg; 1996 Jul; 85(1):14-8. PubMed ID: 8683264
[TBL] [Abstract][Full Text] [Related]
15. Biological relevance of tissue factor and IL-6 in arteriovenous malformations.
Noshiro S; Mikami T; Kataoka-Sasaki Y; Sasaki M; Hashi K; Ohtaki S; Wanibuchi M; Mikuni N; Kocsis JD; Honmou O
Neurosurg Rev; 2017 Jul; 40(3):359-367. PubMed ID: 27542852
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory molecule expression in cerebral arteriovenous malformations.
Storer KP; Tu J; Karunanayaka A; Morgan MK; Stoodley MA
J Clin Neurosci; 2008 Feb; 15(2):179-84. PubMed ID: 17997314
[TBL] [Abstract][Full Text] [Related]
17. Aberrant angiogenic characteristics of human brain arteriovenous malformation endothelial cells.
Jabbour MN; Elder JB; Samuelson CG; Khashabi S; Hofman FM; Giannotta SL; Liu CY
Neurosurgery; 2009 Jan; 64(1):139-46; discussion 146-8. PubMed ID: 19145162
[TBL] [Abstract][Full Text] [Related]
18. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
19. Do cerebral arteriovenous malformations recur after angiographically confirmed total extirpation?
Hashimoto N; Nozaki K
Crit Rev Neurosurg; 1999 May; 9(3):141-146. PubMed ID: 10369967
[TBL] [Abstract][Full Text] [Related]
20. Acquired cerebral arteriovenous malformation induced by an anaplastic astrocytoma: an interesting case.
Harris OA; Chang SD; Harris BT; Adler JR
Neurol Res; 2000 Jul; 22(5):473-7. PubMed ID: 10935219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
